Answers are grounded in this paper and cite their sources.
We assessed the effect of hepatitis B surface antigen (HBsAg) seroclearance (HBsAg-loss) on liver fibrosis regression in patients with chronic hepatitis B (CHB) infection.
No takes yet. Share an insight, caveat, or question.
Mak et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: